Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05547893

Clinical Learning Through Extended Immersion in Medical Simulation (CLEIMS)-A New Approach to Teaching Clinical Ethics

Study objective: This study is planning to develop a new simulation-based ethics education model and evaluate the effectiveness of the model to develop medical students' knowledge, moral reasoning, communication skills, and problem-solving abilities. Several strategies will be conducted to achieve this goal, including faculty development, ethics courses development, and case scenario development.

Methods: The transnational learning and workshops will be arranged for faculty to develop competence for simulation-based ethics education. The workshops will gather the interdisciplinary experts together to discuss and develop the core curriculum and case scenario. The students will be assigned randomly into the simulated clinical ethical situation with simulation patients for the intervention group, and into the workshop discussing clinical ethics case scenario for the control group. The instruments will be developed and the quantitative and qualitative analysis will be conducted.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kaohsiung Medical University Hospital

Kaohsiung, Taiwan, 807

Location status: Recruiting

Location contact

Yenko Lin

CONTACT

[email protected]

+886-7-3121101 ext. 7579

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • medical students in Kaohsiung Medical University
  • agree to participate the study

Exclusion criteria

  • disagree to participate

Treatment and study plan

simulation

Other

participating a simulated clinical ethical situation with simulation patients

Primary outcomes

  1. Defining Issues Test (DIT) and self-developed questionnaire

    Time frame: through study completion, an average of 2 years

    Defining Issues Test (DIT) and self-developed questionnaire for evaluation of moral reasoning

  2. ethical decision-making clinical examination

    Time frame: through study completion, an average of 2 years

    clinical scenario exam designed for testing participants' ability of making ethical decision

  3. Problem Identification Test (PIT) and self-developed questionnaire

    Time frame: through study completion, an average of 2 years

    Problem Identification Test (PIT) and self-developed questionnaire for evaluation of moral sensitivity

  4. knowledge test questionnaire

    Time frame: through study completion, an average of 2 years

    questionnaire for ethics knowledge test

Secondary outcomes

  1. results of Objective Structured Clinical Examination

    Time frame: through study completion, an average of 2 years

    test score of Objective Structured Clinical Examination

  2. participant satisfaction questionnaire

    Time frame: through study completion, an average of 2 years

    satisfaction questionnaire for participating the educational activities

Study contacts

Contact information is provided by the study sponsor or research team.

Yenko Lin

CONTACT

[email protected]

+886-7-3121101 ext. 7579

Sponsors and collaborators

Lead sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital

Other

Registry information

Important dates

Study start
2020
Primary completion
2026
Study completion
2026
First posted
Sep 21, 2022
Registry last updated
Feb 11, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.